Skip to main content
DigiSci

Where AI meets regulated operations.

DigiSci Consulting helps biotech and pharmaceutical organisations design and implement AI transformation strategies that deliver measurable operational value.

THE MOMENT

Biotech has hit an operational turning point.

Advanced therapies have moved faster than the operations meant to make them. Batch sizes of one, living materials, and a chain of identity that cannot fail introduce manufacturing and quality problems with almost no precedent to lean on.

AI could close much of that gap. Most implementations stall at the point where the system has to be validated, evidenced and defended inside an inspected environment, and that scope was never budgeted.

DigiSci Consulting works at the junction between what advanced-therapy operations need and what AI can deliver under GxP.

Cell & Gene TherapyPharma ManufacturingGxP Quality SystemsAI StrategyDigital OperationsRegulated EnvironmentsCDMO Oversight
Gowned operator handling a cell therapy process inside a GMP cleanroom
EXPERIENCE · REGULATED OPERATIONS

Advice grounded in real GxP operational use cases, not just a slide deck. Digisci's founder has extensive operational experience through over two decades in the industry.

WHY DIGISCI

Domain expertise and AI fluency, in one place.

Generalist AI consultancies do not understand GMP. Biotech specialists rarely understand AI. Digisci uniquely applies AI to real business challenges with quantifiable impacts.

Operations leaders reviewing programme data together

Domain depth

Experience with the teams who run tech transfers, close deviations and sign off batch records. The advice comes from being involved.

AI built for validated estates

GAMP 5 categorisation applied per configured module. Data integrity and change control designed in at requirements stage.

Regulatory position

GxP, ALCOA+, Annex 11, Part 11, ISO/IEC 42001 and draft Annex 22 are the starting assumptions of the design.

Strategic clarity

DigiSci Consulting states what is real, what is fixable and what it will cost. One recommendation, signed by the person who delivers it.

WHAT WE DO

Six lines, done at a senior level. Grounded in decades of experience.

See all services →
Delivers · roadmap + business case

AI Transformation Strategy

Where AI creates value in your operation, and the sequence to get there with the validation scope priced in.

Delivers · validated systems, live

AI Implementation Programmes

From use case to production inside a GxP environment, with the validation evidence built as the system is built.

Delivers · data + process architecture

Digital Operations Transformation

The data and document estate every AI use case depends on, diagnosed and redesigned.

Delivers · measurable throughput gains

Operational Excellence

Root-cause deviation reduction, tech-transfer recovery, and CDMO oversight that holds up under inspection.

Delivers · teams fluent in everyday AI

AI Training & Enablement

Immersive programmes built on your own workflows, assessed with a scored instrument.

The seat filled and the work done

Fractional Chief digital officer

A named senior seat carrying the digital and AI agenda, and an advisory track for software providers building for advanced therapy.

Data scientist and operations manager reviewing analytics
THE HARD PART

The technology was never the hard part.

Deploying it under GxP is what breaks most implementations. Data integrity, change control and a defensible audit trail decide whether an AI system survives an inspection.

CLIENT WORK

Recent engagements.

Client details are anonymised at their request. The problems and outcomes are real, as reported by the clients.

All case studies →
AI in Regulated EnvironmentsRegulatory authoring
Global life sciences firm

An AI-enabled regulatory authoring platform

Challenge

Regulatory applications were manually created by SMEs, spending hundreds of consulting hours reviewing hundreds of relevant documents over a 6+ month process.

Approach

We led the programme with the external technology providers, bridging SME needs with the technology providers implementation that exceeds the client specifications.

Impact

Accelerating authoring by 40-60%, while reducing SME resourcing.

Read the case study →
Cell & Gene TherapyQuality systems
Emerging advanced therapy biotech

A digital PQS blueprint for a scaling therapy biotech

Challenge

Batch release ran on disconnected spreadsheets, with batch review averaging 8-10 days as the team scaled for Phase 2.

Approach

We delivered a digital blueprint: identification and quantification of opportunities, an implementation strategy, and multi-vendor evaluations and recommendations.

Impact

Implementation strategy with detailed multi-vendor evaluation assessments, leading to a recommended vendor with full total cost of ownership modelling.

Read the case study →
AI Training
Advanced Therapy Organisation

AI training across a 80-100 FTE organisation

Challenge

Establish AI governance and build AI fluency across a 80-100 FTE organisation.

Approach

We designed an immersive, tiered AI training programme combining classroom and self-learning, grounded in organisational use cases.

Impact

Tailored 3-tiered AI training for 80-100 FTEs, delivered over 3 months. Qualified training metrics to demonstrate adoption.

Read the case study →

LET'S TALK

Have a transformation challenge worth a conversation?